Article
Anti-CD47 immunotherapy as a therapeutic strategy for the treatment of breast cancer brain metastasis
2023-07-25
Abstract excerpt
The presence of cell surface protein CD47 allows cancer cells to evade innate and adaptive immune surveillance resulting in metastatic spread. CD47 binds to and activates SIRPα on the surface of myeloid cells, inhibiting their phagocytic activity. On the other hand, CD47 binds the matricellular protein Thrombospondin-1, limiting T-cell activation. Thus, blocking CD47 is a potential therapeutic strategy for prevent...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c8f6102e-b2bc-56c9-aa41-cda1f3c1c30c
- DOI
- 10.1101/2023.07.25.550566
